Status:
UNKNOWN
New Strategy to Predict Early Sepsis
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Sepsis
Eligibility:
All Genders
19+ years
Brief Summary
This is an observational prospective multicentre study on patients attending the emergency department and suspected to have sepsis. Blood markers characteristic of a Cellular Reprogramming (CR) signat...
Detailed Description
Sepsis is a life-threatening medical condition caused by an infection and the complex and dysfunctional way by which the human body attempts to deal with it. It can affect people of all ages, causing ...
Eligibility Criteria
Inclusion
- Male or female
- Presenting to the Emergency Department
- Attending physician suspects possible sepsis based on at least 2 sign of Systemic inflammatory response syndrome (SIRS) criteria and suspicion of infection
Exclusion
- Patient is terminal (death anticipated in 12 hours)
- Informed consent unobtainable if the subject survives to hospital discharge.
- Subjects who are unable to provide blood as a standard of care.
- Blood sample could not be taken within 24 hours of a physician's first contact with the patient.
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04118179
Start Date
August 1 2018
End Date
July 31 2023
Last Update
June 5 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas, M.D. Anderson Cancer Center
Houston, Texas, United States, 77030
2
Westmead Hospital
Sydney, Australia
3
Vancouver General Hospital
Vancouver, Canada
4
Hospital Universitario Moncaleano Perdomo
Neiva, Colombia